These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28249163)

  • 1. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.
    Saunders KO; Nicely NI; Wiehe K; Bonsignori M; Meyerhoff RR; Parks R; Walkowicz WE; Aussedat B; Wu NR; Cai F; Vohra Y; Park PK; Eaton A; Go EP; Sutherland LL; Scearce RM; Barouch DH; Zhang R; Von Holle T; Overman RG; Anasti K; Sanders RW; Moody MA; Kepler TB; Korber B; Desaire H; Santra S; Letvin NL; Nabel GJ; Montefiori DC; Tomaras GD; Liao HX; Alam SM; Danishefsky SJ; Haynes BF
    Cell Rep; 2017 Feb; 18(9):2175-2188. PubMed ID: 28249163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.
    Alam SM; Aussedat B; Vohra Y; Meyerhoff RR; Cale EM; Walkowicz WE; Radakovich NA; Anasti K; Armand L; Parks R; Sutherland L; Scearce R; Joyce MG; Pancera M; Druz A; Georgiev IS; Von Holle T; Eaton A; Fox C; Reed SG; Louder M; Bailer RT; Morris L; Abdool-Karim SS; Cohen M; Liao HX; Montefiori DC; Park PK; Fernández-Tejada A; Wiehe K; Santra S; Kepler TB; Saunders KO; Sodroski J; Kwong PD; Mascola JR; Bonsignori M; Moody MA; Danishefsky S; Haynes BF
    Sci Transl Med; 2017 Mar; 9(381):. PubMed ID: 28298421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.
    Davis-Gardner ME; Alfant B; Weber JA; Gardner MR; Farzan M
    mBio; 2020 Jan; 11(1):. PubMed ID: 31937648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infection.
    Lavine CL; Lao S; Montefiori DC; Haynes BF; Sodroski JG; Yang X;
    J Virol; 2012 Feb; 86(4):2153-64. PubMed ID: 22156525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
    Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
    Williams WB; Meyerhoff RR; Edwards RJ; Li H; Manne K; Nicely NI; Henderson R; Zhou Y; Janowska K; Mansouri K; Gobeil S; Evangelous T; Hora B; Berry M; Abuahmad AY; Sprenz J; Deyton M; Stalls V; Kopp M; Hsu AL; Borgnia MJ; Stewart-Jones GBE; Lee MS; Bronkema N; Moody MA; Wiehe K; Bradley T; Alam SM; Parks RJ; Foulger A; Oguin T; Sempowski GD; Bonsignori M; LaBranche CC; Montefiori DC; Seaman M; Santra S; Perfect J; Francica JR; Lynn GM; Aussedat B; Walkowicz WE; Laga R; Kelsoe G; Saunders KO; Fera D; Kwong PD; Seder RA; Bartesaghi A; Shaw GM; Acharya P; Haynes BF
    Cell; 2021 May; 184(11):2955-2972.e25. PubMed ID: 34019795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
    LaBranche CC; McGuire AT; Gray MD; Behrens S; Kwong PDK; Chen X; Zhou T; Sattentau QJ; Peacock J; Eaton A; Greene K; Gao H; Tang H; Perez LG; Chen X; Saunders KO; Kwong PD; Mascola JR; Haynes BF; Stamatatos L; Montefiori DC
    PLoS Pathog; 2018 Nov; 14(11):e1007431. PubMed ID: 30395637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.
    Saunders KO; Verkoczy LK; Jiang C; Zhang J; Parks R; Chen H; Housman M; Bouton-Verville H; Shen X; Trama AM; Scearce R; Sutherland L; Santra S; Newman A; Eaton A; Xu K; Georgiev IS; Joyce MG; Tomaras GD; Bonsignori M; Reed SG; Salazar A; Mascola JR; Moody MA; Cain DW; Centlivre M; Zurawski S; Zurawski G; Erickson HP; Kwong PD; Alam SM; Levy Y; Montefiori DC; Haynes BF
    Cell Rep; 2017 Dec; 21(13):3681-3690. PubMed ID: 29281818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env.
    Escolano A; Gristick HB; Gautam R; DeLaitsch AT; Abernathy ME; Yang Z; Wang H; Hoffmann MAG; Nishimura Y; Wang Z; Koranda N; Kakutani LM; Gao H; Gnanapragasam PNP; Raina H; Gazumyan A; Cipolla M; Oliveira TY; Ramos V; Irvine DJ; Silva M; West AP; Keeffe JR; Barnes CO; Seaman MS; Nussenzweig MC; Martin MA; Bjorkman PJ
    Sci Transl Med; 2021 Nov; 13(621):eabk1533. PubMed ID: 34818054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.
    Anthony C; York T; Bekker V; Matten D; Selhorst P; Ferreria RC; Garrett NJ; Karim SSA; Morris L; Wood NT; Moore PL; Williamson C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.
    Doores KJ; Kong L; Krumm SA; Le KM; Sok D; Laserson U; Garces F; Poignard P; Wilson IA; Burton DR
    J Virol; 2015 Jan; 89(2):1105-18. PubMed ID: 25378488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.
    Spencer DA; Malherbe DC; Vázquez Bernat N; Ádori M; Goldberg B; Dambrauskas N; Henderson H; Pandey S; Cheever T; Barnette P; Sutton WF; Ackerman ME; Kobie JJ; Sather DN; Karlsson Hedestam GB; Haigwood NL; Hessell AJ
    J Immunol; 2021 Mar; 206(5):999-1012. PubMed ID: 33472907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to the HIV-1 envelope high mannose patch.
    Daniels CN; Saunders KO
    Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
    Zhang H; Fu H; Luallen RJ; Liu B; Lee FH; Doms RW; Geng Y
    Vaccine; 2015 Sep; 33(39):5140-7. PubMed ID: 26277072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.